INTERNATIONAL PATENT: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS CITE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FILES APPLICATION FOR "AN IN VITRO METHOD FOR ESTABLISHING THE PROGNOSIS OF A SUBJECT DIAGNOSED AS SUFFERING OR HAVING SUFFERED FROM A DIFFUSE LARGE B-CELL LYMPHOMA"

GENEVA, Sept. 21 -- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel-Ange75016 PARIS), UNIVERSITE PARIS CITE (85 Boulevard Saint Germain75006 PARIS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 PARIS) filed a patent application (PCT/EP2025/056972) for "AN IN VITRO METHOD FOR ESTABLISHING THE PROGNOSIS OF A SUBJECT DIAGNOSED AS SUFFERING OR HAVING SUFFERED FROM A DIFFUSE LARGE B-CELL LYMPHOMA" on Mar 13, 2025. With publication no. WO/2025/191110, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization ...